Vancomycin
Cat.No:IV0790 Solarbio
CAS:1404-90-6
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My CartCAS:1404-90-6
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 1404-90-6 |
Name | Vancomycin |
Molecular Formula | C66H75Cl2N9O24 |
Molecular Weight | 1449.25 |
Solubility | Soluble in DMSO(Need ultrasonic) |
Purity | ≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 215-772-6 |
MDL | MFCD05664587 |
SMILES | C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O |
InChIKey | MYPYJXKWCTUITO-LYRMYLQWSA-N |
InChI | InChI=1S/C66H75Cl2N9O24/c1-23(2)12-34(71-5)58(88)76-49-51(83)26-7-10-38(32(67)14-26)97-40-16-28-17-41(55(40)101-65-56(54(86)53(85)42(22-78)99-65)100-44-21-66(4,70)57(87)24(3)96-44)98-39-11-8-27(15-33(39)68)52(84)50-63(93)75-48(64(94)95)31-18-29(79)19-37(81)45(31)30-13-25(6-9-36(30)80)46(60(90)77-50)74-61(91)47(28)73-59(89)35(20-43(69)82)72-62(49)92/h6-11,13-19,23-24,34-35,42,44,46-54,56-57,65,71,78-81,83-87H,12,20-22,70H2,1-5H3,(H2,69,82)(H,72,92)(H,73,89)(H,74,91)(H,75,93)(H,76,88)(H,77,90)(H,94,95)/t24-,34+,35-,42+,44-,46+,47+,48-,49+,50-,51+,52+,53+,54-,56+,57+,65-,66-/m0/s1 |
PubChem CID | 14969 |
Target Point | Bacterial |
Passage | Anti-infection |
Background | Vancomycin is an antibiotic commonly used to treat various bacterial infections. |
Biological Activity | Vancomycin 是一种治疗细菌感染的抗生素。[1-2] |
In Vitro | 万古霉素会改变细胞膜的通透性,并选择性地抑制核糖核酸的合成。万古霉素对大量革兰氏阳性细菌具有活性,对大多数金黄色葡萄球菌菌株具有拮抗作用。[1] |
In Vivo | 万古霉素能在急性期改善艰难梭菌感染小鼠的临床评分和组织病理学,但治疗后效果不佳。减少万古霉素的暴露可减少复发并提高CDI的存活率。[2] |
Data Literature Source | [1]. Watanakunakorn C. Mode of action and in-vitro activity of vancomycin. J Antimicrob Chemother. 1984 Dec;14 Suppl D:7-18. [2]. Warren CA,et al. Vancomycin treatment's association with delayed intestinal tissue injury,clostridial overgrowth,and recurrence of Clostridium difficile infection in mice. Antimicrob Agents Chemother. 2013 Feb;57(2):689-96. |
Unit | Bottle |
Specification | 50mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Early life gut microbiota sustains liver-resident natural killer cells maturation via the butyrate-IL-18 axis
Click to check >>Author:Tian P; Yang W; Guo X; Wang T; Tan S; Sun R; Xiao
IF:17.6940
Publish_to:Nat Commun
PMID:36973277
Gut dysbacteriosis attenuates resistance to Mycobacterium bovis infection by decreasing cyclooxygenase 2 to inhibit endoplasmic reticulum stress
Click to check >>Author:Wang H; Yao J; Chen Y; Wang Y; Liu Y; Liao Y; Lian
IF:13.2000
Publish_to:Emerg Microbes Infect
PMID:35766265
Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis
Click to check >>Author:Bing Han, Xiaodan Lv, Gengfeng Liu, Shiquan Li, Junhua Fan, Lan Chen, Zhixi Huang, Guangfu Lin, Xiaofang Xu, Ziqian Huang, Lingling Zhan, Xiaoping Lv
IF:12.2000
Publish_to:Gut Microbes
PMID:37431863
The effects of pectin on the gut microbiota and serum metabolites in mice fed with a high fat diet and exposed to low-dose antibiotics
Click to check >>Author:Qianhuang Xiao, Wenqi Huang, Quanyong Wu, Hedi Xu, Yanli Zhang, Jingrui Yang, Shuigen Bian, Huizi Tan, Shaoping Nie
IF:6.3170
Publish_to:Food & Function
PMID:37114890
Autoimmune diseases exhibit shared alterations in the gut microbiota
Click to check >>Author:Wang Tianjiao, Sternes Peter R, Guo Xue-Kun, Zhao Huiying, Xu Congmin, Xu Huji
IF:5.5000
Publish_to:RHEUMATOLOGY
PMID:37467058
Tannin extracted from Penthorum chinense Pursh,a potential drug with antimicrobial and antibiofilm effects against methicillin-sensitive Staphylococcus aureus and methicillin-resistant Staphylococcus aureus
Click to check >>Author:Junyuan Qin, Lei Yu, Fu Peng, Xin Ye, Gangmin Li, Chen Sun, Fang Cheng, Cheng Peng, Xiaofang Xie
IF:5.2000
Publish_to:Frontiers in Microbiology
PMID:37465024
Molecular Epidemiology,Antimicrobial Susceptibility,and Toxin Production of Clinical Clostridioides difficile Isolates from a Teaching Hospital in Northern China
Click to check >>Author:Yifeng Liu, Liyan Ma, Wei Sun, Jingwei Cheng, Yaxuan Wang, Jianrong Su
IF:2.9830
Publish_to:DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
PMID:37236133
Fecal Microbiota Transplantation Alleviated Paclitaxel-Induced Peripheral Neuropathy by Interfering with Astrocytes and TLR4/p38MAPK Pathway in Rats
Click to check >>Author:Haibin Shi, Minmin Chen, Caihong Zheng, Bian Yinglin, Bin Zhu
IF:2.7000
Publish_to:Journal of Pain Research
PMID:37483406
Correlation between slow transit constipation and spleen deficiency; and gut microbiota: a pilot study
Click to check >>Author:Zeyue YU; Liyu H; Zongyuan LI; Jianhui S; Hongying C; Hairu H; Xiaoqin LI; Zhongchao S; Hongmei LI.
IF:2.6000
Publish_to:Journal of Traditional Chinese Medicine
PMID:35610004